But researchers from Harvard’s Dana-Farber Cancer Institute recently reported that a specific cannabis flavonoid, FBL-03G, showed ‘significant therapy potential’ in treating pancreatic cancer.
A lab experiment revealed that the flavonoid effectively killed both local and metastatic pancreatic cancer cells - preventing them from spreading further and tumors from growing bigger in the body.
Pancreatic cancer is widely considered one of the most lethal, with just 8% of those diagnosed surviving beyond 5 years. It is notoriously hard to detect and difficult to treat with surgery or chemotherapy once it has spread.
However, a lab result like this means that experimentation can move ahead into clinical trials - a hugely promising development for patients and the medical cannabis industry at large.